Profil
Alison V.
Todd is the founder and currently holds the position of Chief Scientific Officer & General Manager at SpeeDx Pty Ltd.
which she founded in 2009.
She previously worked as a Senior Research Director at Johnson & Johnson Research Pty Ltd.
Dr. Todd received her undergraduate and doctorate degrees from The University of Sydney.
Postes actifs de Alison V. Todd
| Sociétés | Poste | Début |
|---|---|---|
SpeeDx Pty Ltd.
 SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | Fondateur | 08/06/2011 |
Anciens postes connus de Alison V. Todd
| Sociétés | Poste | Fin |
|---|---|---|
| Johnson & Johnson Research Pty Ltd. | Directeur Technique/Scientifique/R&D | - |
Formation de Alison V. Todd
| The University of Sydney | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
SpeeDx Pty Ltd.
SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | Health Technology |
| Johnson & Johnson Research Pty Ltd. |